Jan 25 (Reuters) - Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros ($422.1 million) in a cash and share deal.
The debt-free, cash-free deal will see Dechra paying about 75 percent in cash and 25 percent in new Dechra shares, and subject to a two year lock-in, Dechra said in a statement.
$1 = 0.8055 euros Reporting By Justin George Varghese in Bengaluru; Editing by Gopakumar Warrier
 